Months after $1.9B deal with Bristol Myers, Boston biotech cuts workers


The Boston-based startup blamed the layoffs on "a challenging biotech macroenvironment."

Previous U.S. Bank announces new CFO, chief administration officer
Next RTP firm cutting jobs in US and Europe, will look elsewhere for cheaper labor